The Center for Prisoner Health and Human Rights

Selected Books and Book Chapters:

1. Stein M (1996). "Medical Disorders in Addicted Patients (Chapter)." In: Miller N (Ed.), Addiction Psychiatry: A Comprehensive Textbook. Philadelphia, W.B. Saunders Co.

2. Carpenter CC, Flanigan T, Lederman MM (2000). "HIV Infection and the Acquired Immunodeficiency Syndrome (Chapter)." In: Andreoli T, Carpenter CC, et al. (Ed.), Cecil Essentials of Medicine, 5th Edition. Philadelphia, W.B. Saunders Co.

3. Tashima K, Flanigan T (2000). "Antiretroviral Therapy in the Year 2000. Infectious Disease Clinics of North America." In: Mayer K (Ed.), Philadelphia, W.B. Saunders Co.: 14(14) 827-849.

4. Wachtel TJ, Stein M (2000). "HIV Infection in Older People (Chapter)." In: Gallo J, Busby-Whitehead J, et al. (Ed.), Reichel’s Care of the Elderly: Clinical Aspects of Aging, 5th Edition. Hagerstown, M.D., Lippincott Williams & Wilkins.

5. Carpenter CC, Flanigan T, Lederman MM (2003). "HIV Infection and the Acquired Immunodeficiency Syndrome (Chapter)." In: Andreoli T, Carpenter CC, et al. (Ed.), Cecil Essentials of Medicine, 6th Edition. Philadelphia, W.B. Saunders Co.

6. De Groot AS, Liebel S (2003). "Women in Prison. A Standard of HIV Care (Chapter)." In: Altice F, Selwyn PA, et al. (Ed.), Reaching In, Reaching Out: Treating HIV/AIDS in the Correctional Community. Chicago, National Commission on Correctional Healthcare (NCCHC): 209-223.

7. Holmes L, Mitty J, Flanigan T (2003). "Project Bridge; Combining Case Management with Peer Support (Chapter)." In: Altice F, Selwyn PA, et al. (Ed.), Reaching In, Reaching Out: Treating HIV/AIDS in the Correctional Community. Chicago, National Commission on Correctional Healthcare (NCCHC): 209-223.

8. Libman H, Stein M (2003). "Primary Care and Prevention of HIV Disease (Chapter)." In: Libman H, Makadon H (Ed.), HIV, Third Edition. American College of Physicians -- American Society of Internal Medicine: 39-76.

9. De Groot AS, Liebel S (2005). "Hepatitis B and hepatitis C among offenders within prisons (Chapter)." In: Stojkovic S (Ed.), Managing Special Populations in Jails and Prisons. Milwaukee, Civic Research Institute: 209-223.

10. Maddow R, De Groot AS (2005). "HIV Infection in Incarcerated Women (Chapter)." In: Braithwaite K, Arriola KJ, et al. (Ed.), Health Issues of Incarcerated Women. Rutgers University Press: 209-223.

11. Pizer HF, Mayer K (2005). The AIDS Pandemic: Impact on Science and Society. San Diego, Elsevier Academic Press.

12. Stein M (2005). "Alcohol and Substance Abuse (Chapter 14)." In: Goldberg R (Ed.), Practical Guide to the Care of the Psychiatric Patient, 3rd Edition. Philadelphia, Elsevier Academic Press.

13. Cu Uvin S, Bardeguez A, Chibwesha C (2006). "Vertical Transmission of HIV and Therapeutic Interventions (NRTIs and NNRTIs) (Chapter)." In: Skowron G, Ogden R (Ed.), Reverse Transcriptase Inhibitors in HIV/AIDS Therapy. Humana Press: 425-470.

14. Powrie R, Cu Uvin S (2006). "HIV Infection in Special Populations: HIV Infection in Women." In: Libman H (Ed.), American College of Physicians.

15. Taylor L, Schwartzapfel B, Gholam PM (2006). "Limiting Harm from Chronic Hepatitis C Infection for HIV-Positive People with Drug Dependency: Prevention and Treatment." In: Pizer HF, Mayer K (Ed.), Delivering HIV Care and Treatment for People Who Use Drugs: Lessons from Research and Practice. New York, N.Y., Open Society Institute: 95-109.

16. Greifinger R, Lincoln T, Clear T, et al. (2007). "Screening for Public Purpose: Promoting an Evidence-based Approach to Screening of Inmates to Improve Public Health (Chapter)." In: Greifinger R (Ed.), Public Health Behind Bars: From Prisons to Communities. New York, Springer Publishing.

17. Nijhawan A, Zaller N, Cohen D, et al. (2008). "Interventions with Incarcerated Persons (Chapter)." In: Pizer HF, Mayer K (Ed.), HIV Prevention. San Diego, Elsevier Academic Press.

Peer-Reviewed Publications:

1. Carpenter CC, Mayer KH. (1988). "Advances in AIDS and HIV infection." Adv Intern Med 33:45-79.

2. Carpenter CC, Mayer KH, Fisher A, et al. (1989). "Natural history of acquired immunodeficiency syndrome in women in Rhode Island." Am J Med 86(6 Pt 2):771-775.

3. Carpenter CC, Mayer KH, Stein MD, et al. (1991). "Human immunodeficiency virus infection in North American women: experience with 200 cases and a review of the literature." Medicine (Baltimore) 70(5):307-325.

4. Stein MD, Piette J, Mor V, et al. (1991). "Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons." J Gen Intern Med 6(1):35-40.

5. Flanigan TP, Carpenter CC, Close M. (1992). "HIV infection in the workplace: protecting the vulnerable." Ann Intern Med 117(3):267.

6. Mayer KH, Carpenter CC. (1992). "Women and AIDS." Sci Am 266(3):96.

7. Rich JD, Crawford JM, Kazanjian SN, et al. (1992). "Discrete gastrointestinal mass lesions caused by cytomegalovirus in patients with AIDS: report of three cases and review." Clin Infect Dis 15(4):609-614.

8. Dixon PS, Flanigan TP, DeBuono BA, et al. (1993). "Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge." Am J Med 95(6):629-635.

9. Flanigan TP, Cu-Uvin S, Fiore T, et al. (1993). "HIV infection in Rhode Island women." R I Med 76(9):459-460, 465-456.

10. Rich JD, Buck A, Tuomala RE, et al. (1993). "Transmission of human immunodeficiency virus infection presumed to have occurred via female homosexual contact." Clin Infect Dis 17(6):1003-1005.

11. Rich JD, Sax PE, Kazanjian PH. (1993). "Bacteremic H. influenzae type b infections and HIV." Am J Med 95(1):118-119.

12. Sande MA, Carpenter CC, Cobbs CG, et al. (1993). "Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients." JAMA 270(21):2583-2589.

13. Stein MD, Bonanno J, O'Sullivan PS, et al. (1993). "Changes in the pattern of drug overdoses." J Gen Intern Med 8(4):179-184.

14. Stein MD, O'Sullivan PS, Ellis P, et al. (1993). "Utilization of medical services by drug abusers in detoxification." J Subst Abuse 5(2):187-193.

15. Stein MD, Samet JH, O'Connor PG. (1993). "The linkage of primary care services with substance abuse treatment: new opportunities for academic generalists." J Gen Intern Med 8(2):106-107.

16. Hoy JF, Flanigan TP. (1994). "Wasting associated with cocaine and heroin use in patients infected with human immunodeficiency virus." Clin Infect Dis 19(1):209-210.

17. Flanigan TP. (1995). "HIV testing in prison." Lancet 345(8946):390.

18. Carpenter CC, Fischl MA, Hammer SM, et al. (1996). "Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA." JAMA 276(2):146-154.

19. Cu-Uvin S, Flanigan TP, Rich JD, et al. (1996). "Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women." Am J Med 101(3):316-322.

20. Elliot BC, Rogers M, Rich JD. (1996). "Indeterminate results of HIV testing: explanation and clinical management." Med Health R I 79(10):360-362.

21. Flanigan TP, Uvin SC, Rich JD, et al. (1996). "Update of HIV and AIDS in North America." Med Health R I 79(5):180-187.

22. Lewis DC, Rich JD. (1996). "Physicians should support needle exchange in Rhode Island." Med Health R I 79(6):206.

23. Stein MD, Wilkinson J, Berglas N, et al. (1996). "Prevalence and detection of illicit drug disorders among hospitalized patients." Am J Drug Alcohol Abuse 22(3):463-471.

24. Carpenter CC, Fischl MA, Hammer SM, et al. (1997). "Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel." JAMA 277(24):1962-1969.

25. Farrar DJ, Flanigan TP, Gordon NM, et al. (1997). "Tuberculous brain abscess in a patient with HIV infection: case report and review." Am J Med 102(3):297-301.

26. Feller A, Flanigan TP. (1997). "HIV-infected competitive athletes. What are the risks? What precautions should be taken?" J Gen Intern Med 12(4):243-246.

27. Flanigan TP, Leslie RA. (1997). "Changes in brain gene expression in psychiatric illness: mRNA differential display provides some clues." Mol Psychiatry 2(6):451-456.

28. Pugatch D, Rich JD, Flanigan TP. (1997). "HIV infection in Rhode Island adolescents." Med Health R I 80(10):331-333.

29. Rich JD, Chin-Hong PV, Busi KA, et al. (1997). "Hepatitis C and HIV in male prisoners." J Acquir Immune Defic Syndr Hum Retrovirol 16(5):408-409.

30. Rich JD, Nizam R, Das K, et al. (1997). "HIV and syphilis prevalence in chittagong, Bangladesh." AIDS 11(5):703-704.

31. Rich JD, Ramratnam B, Chiang M, et al. (1997). "Management of indinavir associated nephrolithiasis." J Urol 158(6):2228.

32. Rich JD, Ramratnam B, Flanigan TP. (1997). "Triple combination antiretroviral prophylaxis for needlestick exposure to HIV." Infect Control Hosp Epidemiol 18(3):161.

33. Rich JD, Sullivan T, Greineder D, et al. (1997). "Trimethoprim/sulfamethoxazole incremental dose regimen in human immunodeficiency virus-infected persons." Ann Allergy Asthma Immunol 79(5):409-414.

34. Ruiz R, Cu-Uvin S, Fiore T, et al. (1997). "Toxoplasmosis in HIV-positive women: seroprevalence and the role of prophylaxis in preventing disease." AIDS 11(1):119-120.

35. Stein MD, Cyr MG. (1997). "Women and substance abuse." Med Clin North Am 81(4):979-998.

36. Stein MD, Hanna L. (1997). "Use of mental health services by HIV-infected women." J Womens Health 6(5):569-574.

37. Uvin SC, Flanigan TP. (1997). "Human immunodeficiency virus infection and sexually transmitted diseases." Med Health R I 80(10):334-337.

38. Carpenter CC, Fischl MA, Hammer SM, et al. (1998). "Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel." JAMA 280(1):78-86.

39. Conklin TJ, Lincoln T, Flanigan TP. (1998). "A public health model to connect correctional health care with communities." Am J Public Health 88(8):1249-1250.

40. Cu Uvin S, Caliendo AM, Reinert SE, et al. (1998). "HIV-1 in the female genital tract and the effect of antiretroviral therapy." AIDS 12(7):826-827.

41. Dickinson BP, Mitty JA, Mylonakis E, et al. (1998). "Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care." AIDS 12(15):2075-2076.

42. Mylonakis E, Barlam TF, Flanigan T, et al. (1998). "Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases." Chest 114(1):251-262.

43. Mylonakis E, Koutkia P, Rich JD, et al. (1998). "Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA." AIDS 12(8):958-959.

44. Pugatch D, Mileno M, Rich JD. (1998). "Possible transmission of human immunodeficiency virus type 1 from body piercing." Clin Infect Dis 26(3):767-768.

45. Rich JD, Dickinson BP, Carney JM, et al. (1998). "Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection." AIDS 12(17):2345-2350.

46. Rich JD, Dickinson BP, Liu KL, et al. (1998). "Strict syringe laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users." J Acquir Immune Defic Syndr Hum Retrovirol 18 Suppl 1:S140-141.

47. Rich JD, Dickinson BP, Merriman NA, et al. (1998). "Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter." Am J Gastroenterol 93(9):1598.

48. Rich JD, Dickinson BP, Merriman NA, et al. (1998). "Insulin use by bodybuilders." JAMA 279(20):1613.

49. Rich JD, Dickinson BP, Spaulding A, et al. (1998). "Interpretation of indeterminate HIV serology results in an incarcerated population." J Acquir Immune Defic Syndr Hum Retrovirol 17(4):376-379.

50. Rich JD, Dokson L, Dickinson BP. (1998). "The economic cost of strict syringe control." Med Health R I 81(6):207-208.

51. Stein MD, Freedberg KA, Sullivan LM, et al. (1998). "Sexual ethics. Disclosure of HIV-positive status to partners." Arch Intern Med 158(3):253-257.

52. Stein MD, Mulvey KP, Plough A, et al. (1998). "The functioning and well being of persons who seek treatment for drug and alcohol use." J Subst Abuse 10(1):75-84.

53. Tashima KT. (1998). "Cerebrospinal fluid levels of antiretroviral medications: abstract and commentary." JAMA 280(10):879-880.

54. Chodock R, Mylonakis E, Shemin D, et al. (1999). "Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis--role of haemodialysis treatment." Nephrol Dial Transplant 14(10):2484-2486.

55. Clarke J, Stein MD, Sobota M, et al. (1999). "Victims as victimizers: physical aggression by persons with a history of childhood abuse." Arch Intern Med 159(16):1920-1924.

56. Flanigan TP, Hogan JW, Smith D, et al. (1999). "Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection." Clin Infect Dis 29(3):608-612.

57. Flanigan TP, Rich JD, Spaulding A. (1999). "HIV care among incarcerated persons: a missed opportunity." AIDS 13(17):2475-2476.

58. Mitty JA, McKenzie M, Stenzel M, et al. (1999). "Modified directly observed therapy for treatment of human immunodeficiency virus." JAMA 282(14):1334.

59. Mylonakis E, Dickinson BP, Mileno MD, et al. (1999). "Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy." Am J Hematol 60(2):164-166.

60. Mylonakis E, Merriman NA, Rich JD, et al. (1999). "Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis." Diagn Microbiol Infect Dis 34(2):111-114.

61. Rich JD, Dickinson BP, Feller A, et al. (1999). "The infectious complications of anabolic-androgenic steroid injection." Int J Sports Med 20(8):563-566.

62. Rich JD, Dickinson BP, Flanigan TP, et al. (1999). "Abscess related to anabolic-androgenic steroid injection." Med Sci Sports Exerc 31(2):207-209.

63. Rich JD, Dickinson BP, Flaxman AB, et al. (1999). "Local spread of molluscum contagiosum by electrolysis." Clin Infect Dis 28(5):1171.

64. Rich JD, Dickinson BP, Macalino G, et al. (1999). "Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island." J Acquir Immune Defic Syndr 22(2):161-166.

65. Rich JD, Foisie CK, Towe CW, et al. (1999). "Needle exchange program participation by anabolic steroid injectors, United States 1998." Drug Alcohol Depend 56(2):157-160.

66. Rich JD, Merriman NA, Mylonakis E, et al. (1999). "Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series." Ann Intern Med 130(1):37-39.

67. Rich JD, Mylonakis E, Nossa R, et al. (1999). "Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C." Dig Dis Sci 44(5):1034-1037.

68. Rich JD, Strong L, Towe CW, et al. (1999). "Obstacles to needle exchange participation in Rhode Island." J Acquir Immune Defic Syndr 21(5):396-400.

69. Spaulding AC, Lally M, Rich JD, et al. (1999). "Hepatitis B and C in the context of HIV disease: implications for incarcerated populations." AIDS Read 9(7):481-491.

70. Staszewski S, Morales-Ramirez J, Tashima KT, et al. (1999). "Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team." N Engl J Med 341(25):1865-1873.

71. Stein MD. (1999). "Medical consequences of substance abuse." Psychiatr Clin North Am 22(2):351-370.

72. Stein MD, Samet JH. (1999). "Disclosure of HIV status." AIDS Patient Care STDS 13(5):265-267.

73. Tashima KT, Caliendo AM, Ahmad M, et al. (1999). "Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy." J Infect Dis 180(3):862-864.

74. Vigilante KC, Flynn MM, Affleck PC, et al. (1999). "Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning." J Womens Health 8(3):409-415.

75. Williams SB, Flanigan TP, Artenstein AW, et al. (1999). "CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection." J Infect Dis 179(5):1310-1312.

76. Willy RJ, Salas CM, Macalino GE, et al. (1999). "Long-term non-progression of HIV-1 in a patient coinfected with HTLV-II." Diagn Microbiol Infect Dis 35(4):269-270.

77. Burris S, Lurie P, Abrahamson D, et al. (2000). "Physician prescribing of sterile injection equipment to prevent HIV infection: time for action." Ann Intern Med 133(3):218-226.

78. Carpenter CC. (2000). "Effect of ritonavir on saquinavir metabolism." JAMA 283(22):2936-2937.

79. Carpenter CC, Cooper DA, Fischl MA, et al. (2000). "Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel." JAMA 283(3):381-390.

80. Clarke JG, Cyr MG, Spaulding A. (2000). "Prisons: learning about women's health and substance abuse." Acad Med 75(5):544.

81. Cu-Uvin S, Caliendo AM, Reinert S, et al. (2000). "Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA." AIDS 14(4):415-421.

82. Farley JL, Mitty JA, Lally MA, et al. (2000). "Comprehensive medical care among HIV-positive incarcerated women: the Rhode Island experience." J Womens Health Gend Based Med 9(1):51-56.

83. Feller AA, Flanigan TP. (2000). "HIV, infectious diseases, and competitive athletics." Med Health R I 83(2):56-59.

84. Harrington M, Carpenter CC. (2000). "Hit HIV-1 hard, but only when necessary." Lancet 355(9221):2147-2152.

85. Mylonakis E, Paliou M, Greenbough TC, et al. (2000). "Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus." Arch Intern Med 160(15):2386-2388.

86. Osowiecki DM, Cohen RA, Morrow KM, et al. (2000). "Neurocognitive and psychological contributions to quality of life in HIV-1-infected women." AIDS 14(10):1327-1332.

87. Rich JD, Foisie CK, Towe CW, et al. (2000). "High street prices of syringes correlate with strict syringe possession laws." Am J Drug Alcohol Abuse 26(3):481-487.

88. Rich JD, Strong LL, Mehrotra M, et al. (2000). "Strategies to optimize the impact of needle exchange programs." AIDS Read 10(7):421-429.

89. Stein MD, Rich JD, Maksad J, et al. (2000). "Adherence to antiretroviral therapy among HIV-infected methadone patients: effect of ongoing illicit drug use." Am J Drug Alcohol Abuse 26(2):195-205.

90. Stein MD, Urdaneta ME, Clarke J, et al. (2000). "Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance." J Addict Dis 19(1):85-94.

91. Stenzel MS, Carpenter CC. (2000). "The management of the clinical complications of antiretroviral therapy." Infect Dis Clin North Am 14(4):851-878, vi.

92. Tashima KT, Fiore TC. (2000). "Sustained responses to dual nucleoside therapy in women." J Acquir Immune Defic Syndr 25(4):371-372.

93. Tashima KT, Flanigan TP. (2000). "Antiretroviral therapy in the year 2000." Infect Dis Clin North Am 14(4):827-849.

94. Cannon MJ, Dollard SC, Smith DK, et al. (2001). "Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection." N Engl J Med 344(9):637-643.

95. Charuvastra A, Stein J, Schwartzapfel B, et al. (2001). "Hepatitis B vaccination practices in state and federal prisons." Public Health Rep 116(3):203-209.

96. Clarke JG, Stein MD, Hanna L, et al. (2001). "Active and Former Injection Drug Users Report of HIV Risk Behaviors During Periods of Incarceration." Subst Abus 22(4):209-216.

97. Clarke JG, Stein MD, McGarry KA, et al. (2001). "Interest in smoking cessation among injection drug users." Am J Addict 10(2):159-166.

98. Cohen RA, Boland R, Paul R, et al. (2001). "Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women." AIDS 15(3):341-345.

99. Collier AC, Kalish LA, Busch MP, et al. (2001). "Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial." JAMA 285(12):1592-1601.

100. Cu-Uvin S, Hogan JW, Caliendo AM, et al. (2001). "Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract." Clin Infect Dis 33(6):894-896.

101. Flanigan T, Tashima KT. (2001). "Diagnosis of acute HIV infection: it's time to get moving!" Ann Intern Med 134(1):75-77.

102. Friedmann PD, Lemon SC, Stein MD. (2001). "Transportation and retention in outpatient drug abuse treatment programs." J Subst Abuse Treat 21(2):97-103.

103. Friedmann PD, Lemon SC, Stein MD, et al. (2001). "Linkage to medical services in the Drug Abuse Treatment Outcome Study." Med Care 39(3):284-295.

104. Friedmann PD, Saitz R, Gogineni A, et al. (2001). "Validation of the screening strategy in the NIAAA "Physicians' Guide to Helping Patients with Alcohol Problems"." J Stud Alcohol 62(2):234-238.

105. Mileno MD, Barnowski C, Fiore T, et al. (2001). "Factitious HIV syndrome in young women." AIDS Read 11(5):278-282.

106. Mylonakis E, Paliou M, Rich JD. (2001). "Plasma viral load testing in the management of HIV infection." Am Fam Physician 63(3):483-490, 495-486.

107. Pugatch D, Levesque B, Greene S, et al. (2001). "HIV testing in the setting of inpatient acute substance abuse treatment." Am J Drug Alcohol Abuse 27(3):491-499.

108. Pugatch D, Strong LL, Has P, et al. (2001). "Heroin use in adolescents and young adults admitted for drug detoxification." J Subst Abuse 13(3):337-346.

109. Pugatch DL, Levesque BG, Lally MA, et al. (2001). "HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment." J Acquir Immune Defic Syndr 27(2):135-142.

110. Rich JD, Holmes L, Salas C, et al. (2001). "Successful linkage of medical care and community services for HIV-positive offenders being released from prison." J Urban Health 78(2):279-289.

111. Rich JD, Hou JC, Charuvastra A, et al. (2001). "Risk factors for syphilis among incarcerated women in Rhode Island." AIDS Patient Care STDS 15(11):581-585.

112. Rich JD, Jenny-Avital E. (2001). "Less than optimal?" AIDS Clin Care 13(7):66-67, 70.

113. Rich JD, Macalino GE, McKenzie M, et al. (2001). "Syringe prescription to prevent HIV infection in Rhode Island: a case study." Am J Public Health 91(5):699-700.

114. Rich JD, McKenzie M, Macalino G, et al. (2001). "The genesis of syringe prescription to prevent HIV in Rhode Island." Health Matrix Clevel 11(1):129-145.

115. Rich JD, Whitlock TL, Towe CW, et al. (2001). "Prescribing syringes to prevent HIV: a survey of infectious disease and addiction medicine physicians in Rhode Island." Subst Use Misuse 36(5):535-550.

116. Stein MD, Anderson B, Charuvastra A, et al. (2001). "Alcohol use and sexual risk taking among hazardously drinking drug injectors who attend needle exchange." Alcohol Clin Exp Res 25(10):1487-1493.

117. Stein MD, Friedmann PD. (2001). "Generalist physicians and addiction care: from turfing to sharing the turf." JAMA 286(14):1764-1765.

118. Stein MD, Maksad J, Clarke J. (2001). "Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment." Drug Alcohol Depend 61(3):211-215.

119. Stein MD, Sobota M. (2001). "Injection drug users: hospital care and charges." Drug Alcohol Depend 64(1):117-120.

120. Stenzel MS, McKenzie M, Mitty JA, et al. (2001). "Enhancing adherence to HAART: a pilot program of modified directly observed therapy." AIDS Read 11(6):317-319, 324-318.

121. Tashima KT, Hogan JW, Gardner LI, et al. (2001). "A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use." Clin Infect Dis 33(12):2055-2060.

122. Thomas DL, Rich JD, Schuman P, et al. (2001). "Multicenter evaluation of hepatitis C RNA levels among female injection drug users." J Infect Dis 183(6):973-976.

123. Beckwith CG, Lally MA, Flanigan TP. (2002). "Routine HIV testing among inpatients." Arch Intern Med 162(19):2252-2253; author reply 2253.

124. Desai AA, Latta ET, Spaulding A, et al. (2002). "The importance of routine HIV testing in the incarcerated population: the Rhode Island experience." AIDS Educ Prev 14(5 Suppl B):45-52.

125. DiRienzo AG, van Der Horst C, Finkelstein DM, et al. (2002). "Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection." AIDS Res Hum Retroviruses 18(2):89-94.

126. Falloon J, Ait-Khaled M, Thomas DA, et al. (2002). "HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients." AIDS 16(3):387-396.

127. Feller E, Taylor LE. (2002). "Ten things you may not know about hepatitis C infection." Med Health R I 85(6):180-181.

128. Howard AA, Arnsten JH, Lo Y, et al. (2002). "A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women." AIDS 16(16):2175-2182.

129. Kumarasamy N, Flanigan TP, Mahajan AP, et al. (2002). "Monitoring HIV treatment in the developing world." Lancet Infect Dis 2(11):656-657.

130. Kumarasamy N, Mahajan AP, Flanigan TP, et al. (2002). "Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries." J Acquir Immune Defic Syndr 31(4):378-383.

131. Lally MA, Alvarez S, Macnevin R, et al. (2002). "Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment." Sex Transm Dis 29(12):752-755.

132. Rich JD, Macalino G, Merchant RC, et al. (2002). "HIV seroprevalence of adult males incarcerated for a sexual offense in Rhode Island, 1994-1999." JAMA 288(2):164-165.

133. Rich JD, Martin EG, Macalino GE, et al. (2002). "Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island." J Am Pharm Assoc (Wash) 42(6 Suppl 2):S58-61.

134. Rich JD, Wolf FA, Macalino G. (2002). "Strategies to improve access to sterile syringes for injection drug users." AIDS Read 12(12):527-535.

135. Spaulding A, Stephenson B, Macalino G, et al. (2002). "Human immunodeficiency virus in correctional facilities: a review." Clin Infect Dis 35(3):305-312.

136. Stein MD, Anderson B, Charuvastra A, et al. (2002). "A brief intervention for hazardous drinkers in a needle exchange program." J Subst Abuse Treat 22(1):23-31.

137. Stein MD, Charuvastra A, Anderson B, et al. (2002). "Alcohol and HIV risk taking among intravenous drug users." Addict Behav 27(5):727-736.

138. Stein MD, Charuvastra A, Anderson BJ. (2002). "Social support and zero sharing risk among hazardously drinking injection drug users." J Subst Abuse Treat 23(3):225-230.

139. Stein MD, Friedmann P. (2002). "Need for medical and psychosocial services among injection drug users: a comparative study of needle exchange and methadone maintenance." Am J Addict 11(4):262-270.

140. Tashima KT, Flanigan TP, Kurpewski J, et al. (2002). "Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma." Clin Infect Dis 35(1):82-83.

141. Taylor LE, Costello T, Alt E, et al. (2002). "Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals." AIDS 16(12):1700-1701.

142. Williams SB, Flanigan TP, Cu-Uvin S, et al. (2002). "Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1." Clin Infect Dis 35(5):611-617.

143. Yeni PG, Hammer SM, Carpenter CC, et al. (2002). "Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel." JAMA 288(2):222-235.

144. Allen SA, Spaulding AC, Osei AM, et al. (2003). "Treatment of chronic hepatitis C in a state correctional facility." Ann Intern Med 138(3):187-190.

145. Clarke J, Schwartzapfel B, Pomposelli J, et al. (2003). "Hepatitis B vaccination of incarcerated women: a pilot program." J Health Care Poor Underserved 14(3):318-323.

146. Friedmann PD, Herman DS, Freedman S, et al. (2003). "Treatment of sleep disturbance in alcohol recovery: a national survey of addiction medicine physicians." J Addict Dis 22(2):91-103.

147. Friedmann PD, Lemon SC, Anderson BJ, et al. (2003). "Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS)." Drug Alcohol Depend 69(3):243-251.

148. Friedmann PD, Lemon SC, Stein MD, et al. (2003). "Community referral sources and entry of treatment-naive clients into outpatient addiction treatment." Am J Drug Alcohol Abuse 29(1):105-115.

149. Friedmann PD, Lemon SC, Stein MD, et al. (2003). "Accessibility of addiction treatment: results from a national survey of outpatient substance abuse treatment organizations." Health Serv Res 38(3):887-903.

150. Friedmann PD, Zhang Z, Hendrickson J, et al. (2003). "Effect of primary medical care on addiction and medical severity in substance abuse treatment programs." J Gen Intern Med 18(1):1-8.

151. Harwell JI, Flanigan TP, Mitty JA, et al. (2003). "Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence." AIDS 17(13):1990-1993.

152. Hicks CB, Beckwith CG, Mitty J, et al. (2003). "Confronting the clinical uncertainty regarding syphilis." AIDS Clin Care 15(7):64-65.

153. Kumarasamy N, Solomon S, Chaguturu SK, et al. (2003). "The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India." AIDS 17(15):2267-2269.

154. Kumarasamy N, Solomon S, Flanigan TP, et al. (2003). "Natural history of human immunodeficiency virus disease in southern India." Clin Infect Dis 36(1):79-85.

155. Macalino GE, Ko H, Celentano DD, et al. (2003). "Drug use patterns over time among HIV-seropositive and HIV-seronegative women: the HER study experience." J Acquir Immune Defic Syndr 33(4):500-505.

156. Mayer KH, Hogan JW, Smith D, et al. (2003). "Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy." J Acquir Immune Defic Syndr 33(5):614-624.

157. Mitty JA, Macalino G, Taylor L, et al. (2003). "Directly observed therapy (DOT) for individuals with HIV: successes and challenges." MedGenMed 5(1):30.

158. Powderly WG, Mayer KH. (2003). "Centers for Disease Control and Prevention revised guidelines for human immunodeficiency virus (HIV) counseling, testing, and referral: targeting HIV specialists." Clin Infect Dis 37(6):813-819.

159. Rich JD, Ching CG, Lally MA, et al. (2003). "A review of the case for hepatitis B vaccination of high-risk adults." Am J Med 114(4):316-318.

160. Rich JD, Taylor L, Mehrotra M, et al. (2003). "Prescribing syringes to injection drug users: what the family physician should know." Am Fam Physician 68(1):45-47.

161. Simmons E, Lally MA, Flanigan TP. (2003). "Routine, not risk-based, human immunodeficiency virus testing is the way to go." J Infect Dis 187(6):1024.

162. Simmons EM, Flanigan TP. (2003). "Point of view: the rapid spread of HIV among minority communities in the United States: a call to action." Med Health R I 86(3):83-85.

163. Stancliff S, Agins B, Rich JD, et al. (2003). "Syringe access for the prevention of blood borne infections among injection drug users." BMC Public Health 3:37.

164. Stein MD, Anderson B. (2003). "Injection frequency mediates health service use among persons with a history of drug injection." Drug Alcohol Depend 70(2):159-168.

165. Stein MD, Anderson BJ. (2003). "Nicotine and drug interaction expectancies among methadone maintained cigarette smokers." J Subst Abuse Treat 24(4):357-361.

166. Stein MD, Solomon DA, Herman DS, et al. (2003). "Depression severity and drug injection HIV risk behaviors." Am J Psychiatry 160(9):1659-1662.

167. Tashima KT, Alt EN, Harwell JI, et al. (2003). "Internet sex-seeking leads to acute HIV infection: a report of two cases." Int J STD AIDS 14(4):285-286.

168. Tashima KT, Bausserman L, Alt EN, et al. (2003). "Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens." HIV Clin Trials 4(1):29-36.

169. Tashima KT, Carpenter CC. (2003). "Fusion inhibition--a major but costly step forward in the treatment of HIV-1." N Engl J Med 348(22):2249-2250.

170. Tate D, Paul RH, Flanigan TP, et al. (2003). "The impact of apathy and depression on quality of life in patients infected with HIV." AIDS Patient Care STDS 17(3):115-120.

171. Taylor LE, Runarsdottir V, Zampi A, et al. (2003). "Would you consider prescribing syringes to injection drug users? Addiction Medicine Conference Survey." J Addict Dis 22(1):67-78.

172. Taylor LE, Schwartzapfel B, Allen S, et al. (2003). "Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence." Clin Infect Dis 36(11):1501-1502; author reply 1502-1503.

173. Allen SA, Spaulding AC, Taylor LE, et al. (2004). "Confined treatment continued." Gastroenterology 126(3):928.

174. Boutwell A, Rich JD. (2004). "HIV infection behind bars." Clin Infect Dis 38(12):1761-1763.

175. Boutwell A, Rich JD. (2004). "Syringe access for injection drug users in Rhode Island." Med Health R I 87(1):15-16.

176. De Groot AS, Bishop EA, Khan B, et al. (2004). "Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine." Methods 34(4):476-487.

177. Kumarasamy N, Chaguturu S, Mayer KH, et al. (2004). "Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India." J Acquir Immune Defic Syndr 37(5):1574-1576.

178. Kwara A, Carter EJ, Rich JD, et al. (2004). "Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients." AIDS Patient Care STDS 18(6):341-347.

179. Lurie MN, Carter EJ, Cohen J, et al. (2004). "Directly observed therapy for HIV/tuberculosis co-infection." Lancet Infect Dis 4(3):137-138.

180. Macalino GE, Vlahov D, Sanford-Colby S, et al. (2004). "Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons." Am J Public Health 94(7):1218-1223.

181. Mayer KH, Safren SA, Gordon CM. (2004). "HIV care providers and prevention: opportunities and challenges." J Acquir Immune Defic Syndr 37 Suppl 2:S130-132.

182. Mitty JA, Flanigan TP. (2004). "Community-based interventions for marginalized populations." Clin Infect Dis 38 Suppl 5:S373-375.

183. Rich JD, McKenzie M, Macalino GE, et al. (2004). "A syringe prescription program to prevent infectious disease and improve health of injection drug users." J Urban Health 81(1):122-134.

184. Rich JD, Taylor LE, Allen SA. (2004). "Screening for hepatitis C virus infection in adults." Ann Intern Med 141(7):575-576; author reply 576.

185. Rompalo AM, Shah N, Margolick JB, et al. (2004). "Evaluation of possible effects of continued drug use on HIV progression among women." Int J STD AIDS 15(5):322-327.

186. Stein MD, Herman DS, Bishop S, et al. (2004). "Sleep disturbances among methadone maintained patients." J Subst Abuse Treat 26(3):175-180.

187. Stein MD, Herman DS, Solomon DA, et al. (2004). "Adherence to treatment of depression in active injection drug users: the minerva study." J Subst Abuse Treat 26(2):87-93.

188. Stein MD, Solomon DA, Herman DS, et al. (2004). "Pharmacotherapy plus psychotherapy for treatment of depression in active injection drug users." Arch Gen Psychiatry 61(2):152-159.

189. Stozek MA, Taylor LE, LeBreux L, et al. (2004). "Prescribing syringes to injection drug users with HIV: an important clinical and public health tool." J Assoc Nurses AIDS Care 15(2):59-63.

190. Taylor LE, Rich JD, Tashima KT. (2004). "Peginterferon plus ribavirin for hepatitis C in HIV-infected patients." N Engl J Med 351(22):2340-2342; author reply 2340-2342.

191. Vallabhaneni S, Macalino GE, Reinert SE, et al. (2004). "Prisoners' attitudes toward Hepatitis B vaccination." Prev Med 38(6):828-833.

192. Yeni PG, Hammer SM, Hirsch MS, et al. (2004). "Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel." JAMA 292(2):251-265.

193. Beckwith CG, Flanigan TP, del Rio C, et al. (2005). "Screening for HIV." Ann Intern Med 143(12):916; discussion 916-917.

194. Beckwith CG, Flanigan TP, del Rio C, et al. (2005). "It is time to implement routine, not risk-based, HIV testing." Clin Infect Dis 40(7):1037-1040.

195. Boutwell AE, Allen SA, Rich JD. (2005). "Opportunities to address the hepatitis C epidemic in the correctional setting." Clin Infect Dis 40 Suppl 5:S367-372.

196. Boutwell AE, Rich JD. (2005). "Arrested, addicted: heroin users in the Rhode Island Corrections System." Med Health R I 88(12):421-423.

197. Edlin BR, Kresina TF, Raymond DB, et al. (2005). "Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users." Clin Infect Dis 40 Suppl 5:S276-285.

198. Flanigan TP, Campbell T, Harwell J, et al. (2005). "The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!)." J Infect Dis 191(3):321-323.

199. Flanigan TP, Taylor LE, Mitty JA. (2005). "Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection." Clin Infect Dis 40 Suppl 5:S346-348.

200. Henry K, Bartlett JA, Kojic E, et al. (2005). "Antiretroviral rounds. A communication conundrum." AIDS Clin Care 17(12):115-116.

201. Henry PC, Rich JD. (2005). "Editorial comment: the complexities of homelessness and HIV." AIDS Read 15(11):613.

202. Kumarasamy N, Solomon S, Chaguturu SK, et al. (2005). "The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India." Clin Infect Dis 41(10):1525-1528.

203. Kumarasamy N, Vallabhaneni S, Cecelia AJ, et al. (2005). "Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy." J Acquir Immune Defic Syndr 40(3):377-378.

204. Kumarasamy N, Vallabhaneni S, Flanigan TP, et al. (2005). "Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients." AIDS 19(6):625-627.

205. Kumarasamy N, Vallabhaneni S, Flanigan TP, et al. (2005). "Clinical profile of HIV in India." Indian J Med Res 121(4):377-394.

206. Kwara A, Flanigan TP, Carter EJ. (2005). "Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status." Int J Tuberc Lung Dis 9(3):248-257.

207. Lally MA, MacNevin R, Sergie Z, et al. (2005). "A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center." AIDS Patient Care STDS 19(5):298-305.

208. Macalino GE, Dhawan D, Rich JD. (2005). "A missed opportunity: hepatitis C screening of prisoners." Am J Public Health 95(10):1739-1740.

209. Macalino GE, Vlahov D, Dickinson BP, et al. (2005). "Community incidence of hepatitis B and C among reincarcerated women." Clin Infect Dis 41(7):998-1002.

210. McKenzie M, Macalino G, McClung C, et al. (2005). "Opiate replacement therapy at time of release from incarceration: Project MOD, a pilot program." J Opioid Manag 1(3):147-151.

211. Mitty JA, Macalino GE, Bazerman LB, et al. (2005). "The use of community-based modified directly observed therapy for the treatment of HIV-infected persons." J Acquir Immune Defic Syndr 39(5):545-550.

212. Paul R, Flanigan TP, Tashima K, et al. (2005). "Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus." J Neuropsychiatry Clin Neurosci 17(1):114-118.

213. Paul RH, Brickman AM, Navia B, et al. (2005). "Apathy is associated with volume of the nucleus accumbens in patients infected with HIV." J Neuropsychiatry Clin Neurosci 17(2):167-171.

214. Rich JD, Boutwell AE, Shield DC, et al. (2005). "Attitudes and practices regarding the use of methadone in US state and federal prisons." J Urban Health 82(3):411-419.

215. Rich JD, McKenzie M, Shield DC, et al. (2005). "Linkage with methadone treatment upon release from incarceration: a promising opportunity." J Addict Dis 24(3):49-59.

216. Rosengard C, Clarke JG, DaSilva K, et al. (2005). "Correlates of partner-specific condom use intentions among incarcerated women in Rhode Island." Perspect Sex Reprod Health 37(1):32-38.

217. Simmons EM, Rogers ML, Frierson GM, et al. (2005). "Racial/ethnic attitudes towards HIV testing in the primary care setting." J Natl Med Assoc 97(1):46-52.

218. Spaete JP, Rich JD. (2005). "HIV prevention and care in incarcerated populations." Focus 20(8):1-5.

219. Stein MD, Friedmann PD. (2005). "Disturbed sleep and its relationship to alcohol use." Subst Abus 26(1):1-13.

220. Stein MD, Solomon DA, Anderson BJ, et al. (2005). "Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users." Am J Addict 14(4):346-357.

221. Stein MD, Weinstock MC, Herman DS, et al. (2005). "Respiratory symptom relief related to reduction in cigarette use." J Gen Intern Med 20(10):889-894.

222. Swindells S, Cohen CJ, Berger DS, et al. (2005). "Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens." BMC Infect Dis 5(1):23.

223. Taylor LE. (2005). "Delivering care to injection drug users coinfected with HIV and hepatitis C virus." Clin Infect Dis 40 Suppl 5:S355-361.

224. Taylor LE, Gholam PM, Schwartzapfel B, et al. (2005). "Hepatitis C treatment in an HIV-HCV-coinfected patient with drug addiction and psychiatric illness: a case report." AIDS Read 15(11):629-631, 634-626, 638.

225. Vallabhaneni S, Kumarasamy N, Wing EJ, et al. (2005). "A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy." AIDS Read 15(2):72-75.

226. Zaller N, Noak A, Poshkus M, et al. (2005). "The overlapping epidemics of viral hepatitis/HIV, addiction and incarceration: the situation in Rhode Island." Med Health R I 88(12):424-427.

227. Allen SA. (2006). "A piece of my mind. Dining with Wilkey." JAMA 295(22):2583-2584.

228. Allen SA, Rich JD, Bux RC, et al. (2006). "Deaths of detainees in the custody of US forces in Iraq and Afghanistan from 2002 to 2005." MedGenMed 8(4):46.

229. Beckwith CG, Moreira CC, Aboshady HM, et al. (2006). "A success story: HIV prevention for injection drug users in Rhode Island." Subst Abuse Treat Prev Policy 1:34.

230. Carpenter CC. (2006). "Universal access to antiretroviral therapy: when, not if." Clin Infect Dis 42(2):260-261.

231. Clarke JG, Hebert MR, Rosengard C, et al. (2006). "Reproductive health care and family planning needs among incarcerated women." Am J Public Health 96(5):834-839.

232. Clarke JG, Rosengard C, Rose J, et al. (2006). "Pregnancy attitudes and contraceptive plans among women entering jail." Women Health 43(2):111-130.

233. Clarke JG, Rosengard C, Rose JS, et al. (2006). "Improving birth control service utilization by offering services prerelease vs postincarceration." Am J Public Health 96(5):840-845.

234. Flanigan TP, Beckwith C, Carpenter CC. (2006). "Public health principles for the HIV epidemic." N Engl J Med 354(8):877-878; author reply 877-878.

235. Flanigan TP, Mitty JA. (2006). "The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult." Clin Infect Dis 42(11):1636-1638.

236. Friedmann PD, Hendrickson JC, Gerstein DR, et al. (2006). "Do mechanisms that link addiction treatment patients to primary care influence subsequent utilization of emergency and hospital care?" Med Care 44(1):8-15.

237. Friedmann PD, Rose J, Hayaki J, et al. (2006). "Training primary care clinicians in maintenance care for moderated alcohol use." J Gen Intern Med 21(12):1269-1275.

238. Hammer SM, Saag MS, Schechter M, et al. (2006). "Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel." Top HIV Med 14(3):827-843.

239. Hammer SM, Saag MS, Schechter M, et al. (2006). "Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel." JAMA 296(7):827-843.

240. Kumar PN, Rodriguez-French A, Thompson MA, et al. (2006). "A prospective, 96-week study of the impact of Trizivir, Combivir/nelfinavir, and lamivudine/stavudine/nelfinavir on lipids, metabolic parameters and efficacy in antiretroviral-naive patients: effect of sex and ethnicity." HIV Med 7(2):85-98.

241. Kumarasamy N, Vallabhaneni S, Cecelia AJ, et al. (2006). "Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India." J Acquir Immune Defic Syndr 41(1):53-58.

242. Lai AR, Tashima KT, Taylor LE. (2006). "Antiretroviral medication considerations for individuals coinfected with HIV and hepatitis C virus." AIDS Patient Care STDS 20(10):678-692.

243. Margolis AD, MacGowan RJ, Grinstead O, et al. (2006). "Unprotected sex with multiple partners: implications for HIV prevention among young men with a history of incarceration." Sex Transm Dis 33(3):175-180.

244. McGovern BH, Ditelberg JS, Taylor LE, et al. (2006). "Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients." Clin Infect Dis 43(3):365-372.

245. Merchant RC, Schwartzapfel BL, Wolf FA, et al. (2006). "Demographic, geographic, and temporal patterns of ambulance runs for suspected opiate overdose in Rhode Island, 1997-20021." Subst Use Misuse 41(9):1209-1226.

246. Payne NS, Beckwith CG, Davis M, et al. (2006). "Acceptance of HIV testing among African-American college students at a historically black university in the south." J Natl Med Assoc 98(12):1912-1916.

247. Pugatch D, Anderson BJ, O'Connell JV, et al. (2006). "HIV and HCV testing for young drug users in Rhode Island." J Adolesc Health 38(3):302-304.

248. Rich JD, Anderson BJ, Schwartzapfel B, et al. (2006). "Sexual risk for hepatitis B virus infection among hepatitis C virus-negative heroin and cocaine users." Epidemiol Infect 134(3):478-484.

249. Rich JD, Ghazal M, Mansfield B, et al. (2006). "Specialized STD care in Rhode Island." Med Health R I 89(6):212.

250. Rich JD, Mitty JA, Beckwith CG. (2006). "Editorial comment: correctional opportunities to address the HIV/AIDS epidemic." AIDS Read 16(5):258.

251. Stein MD, Anderson BJ, Lassor J, et al. (2006). "Receipt of disability payments by substance users: mental and physical health correlates." Am J Addict 15(2):160-165.

252. Stein MD, Anderson BJ, Niaura R. (2006). "Nicotine replacement therapy: patterns of use after a quit attempt among methadone-maintained smokers." J Gen Intern Med 21(7):753-757.

253. Stein MD, Weinstock MC, Herman DS, et al. (2006). "A smoking cessation intervention for the methadone-maintained." Addiction 101(4):599-607.

254. Tashima KT, Mitty JA. (2006). "Once-daily therapies for the treatment of HIV infection." Curr HIV/AIDS Rep 3(2):86-92.

255. Vallabhaneni S, Macalino GE, Reinert SE, et al. (2006). "Prisoners favour hepatitis C testing and treatment." Epidemiol Infect 134(2):243-248.

256. Zaller ND, Thurmond P, Brett J, et al. (2006). "Linkage to methadone treatment from acute opiate detoxification treatment." J Opioid Manag 2(6):341-346.

257. Allen SA, Rich JD. (2007). "Prisons and mental health." N Engl J Med 356(2):197-198.

258. Beckwith CG, Atunah-Jay S, Cohen J, et al. (2007). "Feasibility and acceptability of rapid HIV testing in jail." AIDS Patient Care STDS 21(1):41-47.

259. Beckwith CG, Cohen J, Shannon C, et al. (2007). "HIV testing experiences among male and female inmates in Rhode Island." AIDS Read 17(9):459-464.

260. Beckwith CG, Zaller N, Flanigan TP. (2007). "HIV counseling and testing among injection drug users needs to continue." Am J Public Health 97(7):1161.

261. Beletsky L, Ruthazer R, Macalino GE, et al. (2007). "Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities." J Urban Health 84(1):126-136.

262. Brim N, Zaller N, Taylor LE, et al. (2007). "Twinrix vaccination schedules among injecting drug users." Expert Opin Biol Ther 7(3):379-389.

263. Cohen DE, Mayer KH. (2007). "Primary care issues for HIV-infected patients." Infect Dis Clin North Am 21(1):49-70, viii.

264. Freedberg KA, Kumarasamy N, Losina E, et al. (2007). "Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy." AIDS 21 Suppl 4:S117-128.

265. Kacanek D, Eldridge GD, Nealey-Moore J, et al. (2007). "Young incarcerated men's perceptions of and experiences with HIV testing." Am J Public Health 97(7):1209-1215.

266. Kumarasamy N, Flanigan TP, Vallabhaneni S, et al. (2007). "A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India." AIDS Care 19(4):507-513.

267. Lally MA, Lemei K, Bonney LE, et al. (2007). "HPV vaccination an opportune time for HIV testing." J Adolesc Health 40(4):384; author reply 384-385.

268. Macalino GE, Hogan JW, Mitty JA, et al. (2007). "A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users." AIDS 21(11):1473-1477.

269. McKenzie M, Rich JD. (2007). "Heroin in the corrections system: introduction." Med Health R I 90(5):140-141.

270. Rich JD. (2007). "Health Issues in Prisons and Jails." J Urban Health.

271. Rich JD, Hogan JW, Wolf F, et al. (2007). "Lower syringe sharing and re-use after syringe legalization in Rhode Island." Drug Alcohol Depend 89(2-3):292-297.

272. Riddler SA, Jiang H, Tenorio A, et al. (2007). "A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115." Antivir Ther 12(4):531-541.

273. Schwartz RP, McKenzie M, Rich JD. (2007). "Opioid addiction and incarceration: an overview." Med Health R I 90(5):157-158.

274. Spaulding AC, Allen SA, Stone A. (2007). "Mortality after release from prison." N Engl J Med 356(17):1785; author reply 1786-1787.

275. Stein MD, Dubyak P, Herman D, et al. (2007). "Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative." Am J Drug Alcohol Abuse 33(4):517-525.

276. Stein MD, Herman DS, Bishop D, et al. (2007). "A telephone-based intervention for depression in HIV patients: negative results from a randomized clinical trial." AIDS Behav 11(1):15-23.

277. Stein MD, Weinstock MC, Anderson BJ, et al. (2007). "Relationship of depression to smoking outcomes in a methadone-maintained population." J Addict Dis 26(1):35-40.

278. Subbaraman R, Chaguturu SK, Mayer KH, et al. (2007). "Adverse effects of highly active antiretroviral therapy in developing countries." Clin Infect Dis 45(8):1093-1101.

279. Tedeschi SK, Bonney LE, Manalo R, et al. (2007). "Vaccination in juvenile correctional facilities: state practices, hepatitis B, and the impact on anticipated sexually transmitted infection vaccines." Public Health Rep 122(1):44-48.

280. Zaller N. (2007). "Drug court as an alternative to incarceration." Med Health R I 90(5):154-156.

281. Zaller N, Dawalt M, Beckwith C, et al. (2007). "Routine HIV testing in US prisons." Lancet Infect Dis 7(7):440-441.

282. Zaller N, Thurmond P, Rich JD. (2007). "Limited spending: an analysis of correctional expenditures on antiretrovirals for HIV-infected prisoners." Public Health Rep 122(1):49-54.